Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 01 12:16PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-6.52 Insider Own0.41% Shs Outstand10.01M Perf Week27.15%
Market Cap5.40M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float9.97M Perf Month59.12%
Income-26.16M PEG- EPS next Q- Inst Own2.68% Short Float0.45% Perf Quarter23.90%
Sales3.07M P/S1.76 EPS this Y- Inst Trans- Short Ratio0.23 Perf Half Y208.06%
Book/sh0.27 P/B2.02 EPS next Y- ROA-102.41% Short Interest0.04M Perf Year-49.14%
Cash/sh0.03 P/C18.61 EPS next 5Y- ROE-314.91% 52W Range0.17 - 3.84 Perf YTD28.36%
Dividend Est.- P/FCF- EPS past 5Y67.03% ROI-475.06% 52W High-85.96% Beta-0.79
Dividend TTM- Quick Ratio0.18 Sales past 5Y0.48% Gross Margin6.62% 52W Low226.73% ATR (14)0.04
Dividend Ex-Date- Current Ratio0.28 EPS Y/Y TTM64.39% Oper. Margin-597.83% RSI (14)70.47 Volatility7.58% 10.67%
Employees100 Debt/Eq4.68 Sales Y/Y TTM-7.28% Profit Margin-852.11% Recom3.00 Target Price3.00
Option/ShortNo / Yes LT Debt/Eq1.06 EPS Q/Q92.18% Payout- Rel Volume4.35 Prev Close0.48
Sales Surprise-22.33% EPS Surprise-6.98% Sales Q/Q55.78% EarningsNov 14 AMC Avg Volume193.43K Price0.54
SMA2031.18% SMA5037.38% SMA20010.35% Trades Volume382,569 Change12.88%
Date Action Analyst Rating Change Price Target Change
Mar-01-19Initiated Alliance Global Partners Buy $2.30
Feb-07-18Reiterated H.C. Wainwright Buy $1 → $9
Jun-29-16Initiated Rodman & Renshaw Buy $2.50
Nov-14-23 04:30PM
Oct-12-23 12:32PM
Sep-29-23 08:22AM
07:46AM Loading…
Aug-13-23 07:46AM
Aug-11-23 06:18AM
Aug-10-23 04:15PM
Aug-07-23 07:30AM
Aug-03-23 08:00AM
Jul-19-23 07:30AM
Jun-26-23 07:30AM
Jun-22-23 07:30AM
Jun-20-23 07:30AM
06:43AM Loading…
May-16-23 06:43AM
May-15-23 04:15PM
May-08-23 07:30AM
May-04-23 04:30PM
May-01-23 09:00PM
Apr-26-23 04:30PM
Apr-19-23 08:38AM
Apr-18-23 04:30PM
Apr-05-23 07:30AM
Apr-03-23 07:30AM
Apr-01-23 10:44PM
Mar-30-23 02:25PM
Mar-29-23 04:15PM
07:30AM Loading…
Mar-22-23 07:30AM
Mar-01-23 07:30AM
Feb-17-23 07:30AM
Jan-26-23 07:30AM
Jan-18-23 07:30AM
Jan-17-23 07:30AM
Jan-11-23 04:30PM
Jan-06-23 08:00PM
Jan-04-23 04:30PM
Dec-13-22 09:44AM
Nov-10-22 04:10PM
Oct-27-22 07:30AM
Oct-25-22 07:30AM
Oct-03-22 04:20PM
Sep-30-22 08:38AM
Sep-20-22 07:30AM
Sep-06-22 07:30AM
Aug-31-22 07:30AM
Aug-25-22 07:30AM
Aug-11-22 04:15PM
Jul-28-22 07:30AM
Jul-26-22 07:30AM
Jul-08-22 07:30AM
Jun-27-22 11:22PM
Jun-22-22 08:00AM
Jun-09-22 07:30AM
May-26-22 07:30AM
May-12-22 05:35PM
Apr-28-22 07:30AM
Apr-25-22 07:30AM
Apr-20-22 07:30AM
Apr-06-22 07:30AM
Apr-05-22 07:30AM
Mar-29-22 07:25PM
Mar-24-22 07:05PM
Mar-15-22 07:30AM
Feb-28-22 07:55PM
Feb-10-22 04:30PM
Jan-18-22 07:30AM
Jan-10-22 07:30AM
Dec-14-21 07:30AM
Dec-08-21 04:30PM
Nov-30-21 08:45AM
Nov-11-21 04:05PM
Nov-04-21 03:01PM
Oct-28-21 07:30AM
Oct-21-21 07:30AM
Oct-18-21 04:30PM
Oct-14-21 08:00AM
Oct-05-21 05:17AM
Oct-04-21 02:59PM
Sep-30-21 07:30AM
Sep-16-21 09:03AM
OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It engages in the development of molecular information products and services for global healthcare settings. The firm's also offers guidance to clinicians about life threatening infections, improving patient outcomes, and decreasing the spread of infections caused by multidrug-resistant microorganisms. Its products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction. The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bacher JohannesChief Operating OfficerMar 31Option Exercise0.006,434012,684Mar 31 04:30 PM
Schacht OliverChief Executive OfficerMar 31Option Exercise0.0012,469019,719Mar 31 04:30 PM
Schacht OliverChief Executive OfficerMar 03Option Exercise0.001,93807,250Mar 06 05:15 PM
Bacher JohannesChief Operating OfficerMar 03Option Exercise0.001,06306,250Mar 06 05:13 PM
Bacher JohannesChief Operating OfficerMar 02Option Exercise0.001,12505,187Mar 06 05:13 PM
Schacht OliverChief Executive OfficerMar 02Option Exercise0.001,87505,312Mar 06 05:15 PM